Arden Trust’s Enzo Biochem, Inc. ENZ Stock Holding History

Arden Trust’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,296	Closed	-$46K	–	670
2015 Q4	$46K	Hold	10,296	–	–	﹤0.01%	638
2015 Q3	$33K	Buy	+10,296	New	+$31.2K	﹤0.01%	721

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Arden Trust's ENZ Position: Q1 2016 in Review

Arden Trust sold out of Enzo Biochem, Inc. (ENZ) in Q1 2016, closing a stake of 10,296 shares — an estimated $46K sold.

Arden Trust first reported a position in ENZ in Q3 2015 and held it in 2 quarters. The position peaked at $46K in Q4 2015. 99 funds tracked by Wall St. Rank hold ENZ as of Q1 2016.

Arden Trust reported no remaining Enzo Biochem, Inc. position as of Q1 2016 after selling out during the quarter.
Arden Trust sold 10,296 Enzo Biochem, Inc. shares in Q1 2016, an estimated $46K.
Arden Trust first reported a position in Enzo Biochem, Inc. in Q3 2015 and held it in 2 quarters.
Arden Trust's Enzo Biochem, Inc. position peaked at $46K in Q4 2015.
99 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2016.

Based on Arden Trust's 13F filing for Q1 2016, filed 18 May 2016.